Trust Investment Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$833K |
| 2 |
BorgWarner
BWA
|
+$831K |
| 3 |
Qualcomm
QCOM
|
+$688K |
| 4 |
Salesforce
CRM
|
+$433K |
| 5 |
JB Hunt Transport Services
JBHT
|
+$425K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ResMed
RMD
|
+$954K |
| 2 |
Lear
LEA
|
+$640K |
| 3 |
Microsoft
MSFT
|
+$517K |
| 4 |
Apple
AAPL
|
+$446K |
| 5 |
Casey's General Stores
CASY
|
+$412K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.14% |
| 2 | Consumer Discretionary | 17.23% |
| 3 | Industrials | 11.81% |
| 4 | Healthcare | 10.39% |
| 5 | Energy | 7.23% |
Similar funds
Trust Investment Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Trust Investment Advisors held 85 positions worth $79.4M, down 6.4% from $84.9M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trust Investment Advisors withdrew a net $6.13M in Q2 2019, closing 4 positions and reducing 66 holdings. Its most notable exit was ResMed, an estimated $954K position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Trust Investment Advisors opened a new position in NXP Semiconductors worth $839K.
- Trust Investment Advisors's largest Q2 2019 buy was NXP Semiconductors: 8,595 shares worth $839K.
- Trust Investment Advisors added most to Kohl's in Q2 2019, an estimated $43.7K increase.
- Trust Investment Advisors's biggest Q2 2019 reduction was Microsoft, cutting an estimated $517K.
- Trust Investment Advisors fully exited ResMed in Q2 2019, selling an estimated $954K.
- Trust Investment Advisors's ten largest holdings make up 31% of its $79.4M portfolio in Q2 2019.
- Trust Investment Advisors opened 6 new positions and closed 4 in Q2 2019.
- Trust Investment Advisors's portfolio value fell 6.4% quarter-over-quarter to $79.4M.
Based on Trust Investment Advisors's 13F filing for Q2 2019, filed 30 Jul 2019.